Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

By Yahoo! Finance | Aug 9, 2024 at 06:38 AM EST

Amphastar Pharmaceuticals saw a rise in profit margin from 18% to 21%, driven by increased revenue. Despite beating revenue estimates, EPS fell short. Future revenue growth is forecasted at 11% annually. One warning sign was identified. Contact Simply Wall St for feedback.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.